Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - plaučių liga, lėtinė obstrukcinė - formoterol ir glycopyrronium bromidas - bevespi aerosphere yra nurodyta, kaip techninės priežiūros bronchus gydymas, siekiant palengvinti simptomus, suaugusiųjų pacientams, sergantiems lėtine obstrukcine plaučių liga (lopl).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - kiaulės - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresantai - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - visi kiti gydomieji produktai - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - narkotikų gydymo hyperkalemia ir hyperphosphatemia - velforas skiriamas serumo fosforo koncentracijai kontroliuoti suaugusių lėtinių inkstų ligos (ckd) pacientams, kuriems atliekama hemodializė (hd) arba peritoninė dializė (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - citomegalovirusinės infekcijos - antivirusiniai vaistai sisteminiam naudojimui - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antivirusinių medžiagų.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

covis pharma europe b.v. - formoterol fumarate dihydrate, aclidinium bromide - plaučių liga, lėtinė obstrukcinė - vaistai nuo obstrukcinių kvėpavimo takų ligų, - brimica genuair yra kaip palaikomojo bronchodilatatoriaus gydymas oro srauto obstrukcijai ir simptomų palengvinimui suaugusiems pacientams, sergantiems lėtiniu obstrukcine plaučių liga (lopl).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

laboratoires delbert - histamino dihidrochloridas - leukemija, mieloidas, ūmus - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). ceplene veiksmingumas pacientams, vyresniems nei 60 metų amžiaus, nebuvo visiškai įrodytas.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

ultragenyx germany gmbh - evinacumab - hipercholesterolemija - lipidą keičiančios medžiagos - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).